Trial Profile

A Phase 1, Single and Multiple Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 Injection in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TB 001 (Primary)
Indications Unspecified
Focus Adverse reactions
Sponsors Shenzhen Turier Biotech

Most Recent Events

12 Apr 2023 Status changed from recruiting to completed.
12 Apr 2022 New trial record
04 Apr 2022 Arms amended from 2 to 4. SAD and MSD stages added newly in intervention arms for TB001 and placebo.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com